Proinsulin C-peptide activates α-enolase: Implications for C-peptide-cell membrane interaction

Journal of Biochemistry

Volumn 152, Issue 1, 2012, Pages 53-62

  Ishii, Tatsuya ^a   Fukano, Keigo ^a   Shimada, Kohei ^a   Kamikawa, Akihiro ^a,b   Okamatsu Ogura, Yuko ^a   Terao, Akira ^a   Yoshida, Toshihide ^c   Saito, Masayuki ^d   Kimura, Kazuhiro ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b OBIHIRO UNIVERSITY OF AGRICULTURE AND VETERINARY MEDICINE   (Japan)

^c KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^d TENSHI COLLEGE   (Japan)

Author keywords

enolase; C peptide; ENO1; MAP kinase; plasminogen

Indexed keywords

ALANINE; ALPHA ENOLASE; ARGININE; C PEPTIDE; CELL SURFACE PROTEIN; CELL SURFACE RECEPTOR; GLUTAMIC ACID; LYSINE; MEMBRANE PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PLASMINOGEN; RECOMBINANT ENZYME;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL MEMBRANE; CONTROLLED STUDY; CROSS LINKING; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN TISSUE; IMMUNOPRECIPITATION; MASS SPECTROMETRY; NUCLEOTIDE SEQUENCE; PROTEIN INTERACTION;

AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; C-PEPTIDE; CELL MEMBRANE; CELLS, CULTURED; HL-60 CELLS; HUMANS; MOLECULAR SEQUENCE DATA; PHOSPHOPYRUVATE HYDRATASE;

EID: 84863680364     PISSN: 0021924X     EISSN: 17562651     Source Type: Journal    
DOI: 10.1093/jb/mvs052     Document Type: Article

References (48)

1. Wahren, J., Ekberg, K., Johansson, J., Henriksson, M., Pramanik, A., Johansson, B.L., Rigler, R., and Jörnvall, H. (2000) Role of C-peptide in human physiology. Am. J. Physiol. Endocrinol. Metab. 278, E759-E768
2. Wahren, J. (2004) C-peptide: new findings and therapeutic implications in diabetes. Clin. Physiol. Funct. Imag. 24, 180-189
3. Haidet, J., Cifarelli, V., Trucco, M., and Luppi, P. (2009) Anti-inflammatory properties of C-peptide. Rev. Diabet. Stud. 6, 168-179
4. Kamiya, H., Zhang, W., and Sima, A.A. (2009) The beneficial effects of C-Peptide on diabetic polyneuropathy. Rev. Diabet. Stud. 6, 187-202
5. Hills, C.E., Brunskill, N.J., and Squires, P.E. (2010) C-peptide as a therapeutic tool in diabetic nephropathy. Am. J. Nephrol. 31, 389-397
6. Johansson, B.L., Sjoberg, S., and Wahren, J. (1992) The influence of human C-peptide on renal function and glucose utilization in type 1 (insulin-dependent) diabetic patients. Diabetologia 35, 121-128
7. Johansson, B.L., Kernell, A., Sjoberg, S., and Wahren, J. (1993) Influence of combined C-peptide and insulin administration on renal function and metabolic control in diabetes type 1. J. Clin. Endocrinol. Metab. 77, 976-981
8. Sjoquist, M., Huang, W., and Johansson, B.L. (1998) Effects of C-peptide on renal function at the early stage of experimental diabetes. Kidney Int. 54, 758-764
9. Samnegard, B., Jacobson, S.H., Jaremko, G., Johansson, B.L., and Sjoquist, M. (2001) Effects of C-peptide on glomerular and renal size and renal function in diabetic rats. Kidney Int. 60, 1258-1265
10. Huang, D.-Y., Richter, K., Breidenbach, A., and Vallon, V. (2002) Human C-peptide acutely lowers glomerular hyperfiltration and proteinuria in diabetic rats: a dose-response study. Naunyn-Schmiedeberg's Arch. Pharmacol. 365, 67-73
11. Rebsomen, L., Pitel, S., Boubred, F., Buffat, C., Feuerstein, J.M., Raccah, D., Vague, P., and Tsimaratos, M. (2006) C-peptide replacement improves weight gain and renal function in diabetic rats. Diabetes Metab. 32, 223-228
12. Kamikawa, A., Ishii, T., Shimada, K., Makondo, K., Inanami, O., Sakane, N., Yoshida, T., Saito, M., and Kimura, K. (2008) Proinsulin C-peptide abrogates type-1 diabetes-induced increase of renal endothelial nitric oxide synthase in rats. Diabetes Metab. Res. Rev. 24, 331-338
13. Ido, Y., Vindigni, A., Chang, K., Stramm, L., Chance, R., Heath, W.F., DiMarchi, R.D., Di Cera, E., and Williamson, J.R. (1997) Prevention of vascular and neural dysfunction in diabetic rats by C-peptide. Science 277, 563-566
14. Johansson, B.L., Linde, B., and Wahren, J. (1992) Effects of C-peptide on blood flow, capillary diffusion capacity and glucose utilization in the exercising forearm of type 1 (insulin-dependent) diabetic patients. Diabetologia 35, 1151-1158
15. Zierath, J.R., Handberg, A., Tally, M., and Wallberg-Henriksson, H. (1996) C-peptide stimulates glucose transport in isolated human skeletal muscle independent of insulin receptor and tyrosine kinase activation. Diabetologia 39, 306-313
16. Lindstrom, K., Johansson, C., Johnsson, E., and Haraldsson, B. (1996) Acute effects of C-peptide on the microvasculature of isolated perfused skeletal muscles and kidneys in rat. Acta Physiol. Scand. 156, 19-25
17. Johansson, B.L., Borg, K., Fernqvist-Forbes, E., Odergre, T., Remahl, S., and Wahren, J. (1996) C-peptide improves autonomic nerve function in IDDM patients. Diabetologia 39, 687-695
18. Forst, T., Kunt, T., Pohlmann, T., Goitom, K., Engelbach, M., Beyer, J., and Pfutzner, A. (1998) Biological activity of C-peptide on the skin microcirculation in patients with insulin-dependent diabetes mellitus. J. Clin. Invest. 101, 2036-2041
19. Mughal, R.S., Scragg, J.L., Lister, P., Warburton, P., Riches, K., O'Regan, D.J., Ball, S.G., Turner, N.A., and Porter, K.E. (2010) Cellular mechanisms by which proinsulin C-peptide prevents insulin-induced neointima formation in human saphenous vein. Diabetologia 53, 1761-1771
20. Kobayashi, Y., Naruse, K., Hamada, Y., Nakashima, E., Kato, K., Akiyama, N., Kamiya, H., Watarai, A., Nakae, M., Oiso, Y., and Nakamura, J. (2005) Human proinsulin C-peptide prevents proliferation of rat aortic smooth muscle cells cultured in high-glucose conditions. Diabetologia 48, 2396-2401
21. Sima, A.A., Zhang, W., Kreipke, C.W., Rafols, J.A., and Hoffman, W.H. (2009) Inflammation in diabetic encephalopathy is prevented by C-Peptide. Rev. Diabet. Stud. 6, 37-42
22. Vish, M.G., Mangeshkar, P., Piraino, G., Denenberg, A., Hake, P.W., O'Connor, M., and Zingarelli, B. (2007) Proinsulin C-peptide exerts beneficial effects in endotoxic shock in mice. Crit. Care Med. 35, 1348-1355
23. Rigler, R., Pramanik, A., Jonasson, P., Kratz, G., Jansson, O.T., Nygren, P.-A., Stahl, S., Ekberg, K., Johansson, B.L., Uhlen, S., Jornvall, H., and Wahren, J. (1999) Specific binding of proinsulin C-peptide to human cell membranes. Proc. Natl. Acad. Sci. USA 96, 13318-13323
24. Kitamura, T., Kimura, K., Jung, B.D., Makondo, K., Okamoto, S., Canas, X., Sakane, N., Yoshida, T., and Saito, M. (2001) Proinsulin C-peptide rapidly stimulates mitogen-activated protein kinases in Swiss 3T3 fibroblasts: requirement of protein kinase C, phosphoinositide 3-kinase and pertussis toxin-sensitive G-protein. Biochem. J. 355, 123-129
25. Kitamura, T., Kimura, K., Jung, B.D., Makondo, K., Sakane, N., Yoshida, T., and Saito, M. (2002) Proinsulin C-peptide activates cAMP response element-binding proteins through the p38 mitogenactivated protein kinase pathway in mouse lung capillary endothelial cells. Biochem. J. 366, 737-744
26. Kitamura, T., Kimura, K., Makondo, K., Furuya, D.T., Suzuki, M., Yoshida, T., and Saito, M. (2003) Proinsulin C-peptide increases nitric oxide production through mitogen-activated protein kinase-dependent transcriptional enhancement of endothelial nitric oxide synthase in rat aortic endothelial cells. Diabetologia 46, 1698-1705
27. Marx, N., Walcher, D., Raichle, C., Aleksic, M., Bach, H., Grub, M., Hombach, V., Libby, P., Zieske, A., Homma, S., and Strong, J. (2004) C-peptide colocalizes with macrophages in early arteriosclerotic lesions of diabetic subjects and induces monocyte chemotaxis in vitro. Arterioscler. Thromb. Vasc. Biol. 24, 540-545
28. Walcher, D., Aleksic, M., Jerg, V., Hombach, V., Zieske, A., Homma, S., Strong, J., and Marx, N. (2004) C-peptide induces chemotaxis of human CD4-positive cells. Diabetes 53, 1664-1670
29. Lowry, O.H., Rosebrough, N.J., Farr, A.L., and Randall, R.J. (1951) Protein measurement with the folin phenol reagent. J. Biol. Chem. 193, 265-275
30. Gentile, F., Pizzimenti, S., Arcaro, A., Pettazzoni, P., Minelli, R., D'Angelo, D., Mamone, G., Ferranti, P., Toaldo, C., Cetrangolo, G., Formisano, S., Dianzani, M.U., Uchida, K., Dianzani, C., and Barrera, G. (2009) Exposure of HL-60 human leukaemic cells to 4-hydroxynonenal promotes the formation of adduct(s) with alpha-enolase devoid of plasminogen binding activity. Biochem. J. 422, 285-294
31. Miles, L.A., Dahlberg, C.M., Plescia, J., Felez, J., Kato, K., and Plow, E.F. (1991) Role of cell-surface lysine in plasminogen binding to cells: identification of alpha-enolase as a candidate plasminogen receptor. Biochemistry 30, 1682-1691
32. Plow, E.F. and Das, R. (2009) Enolase-1 as a plasminogen receptor. Blood 113, 5371-5372
33. De Sousa, L.P., Brasil, B.S., Silva, B.M., Freitas, M.H., Nogueira, S.V., Ferreira, P.C., Kroon, E.G., and Bonjardim, C.A. (2005) Plasminogen/plasmin regulates c-fos and egr-1 expression via the MEK/ERK pathway. Biochem. Biophys. Res. Commun. 329, 237-245
34. Paramanik, A., Ekberg, K., Zhong, Z., Shafqat, J., Henriksson, M., Jansson, O., Tibell, A., Tally, M., Wahren, J., Jornvall, H., Rigler, R., and Johasson, J. (2001) C-peptide binding to human cell membranes: importance of Glu27. Biochem. Biophys. Res. Commun. 284, 94-98
35. Mor, I., Bruck, T., Greenburg, D., Berson, A., Schreiber, L., Grisaru, D., and Soreq, H. (2008) Alternate AChE-R variants facilitate cellular metabolic activity and resistance to genotoxic stress through enolase and RACK1 interactions. Chem.-Biol. Interact. 175, 11-21
36. Shephard, E.G., Anderson, R., Rosen, O., and Fridkin, M. (1992) C-reactive protein (CRP) peptides inactivate enolase in human neutrophils leading to depletion of intracellular ATP and inhibition of superoxide generation. Immunology 76, 79-85
37. Kang, H.J., Jung, S.-K., Kim, S.J., and Chung, S.J. (2008) Structure of human a-enolase (hENO1), a multifunctional glycolytic enzyme. Acta Cryst D 64, 651-657
38. Shafqat, J., Melles, E., Sigmundsson, K., Johansson, B.L., Ekberg, K., Alvelius, G., Henriksson, M., Johansson, J., Wahren, J., and Jörnvall, H. (2006) Proinsulin C-peptide elicits disaggregation of insulin resulting in enhanced physiological insulin effects. Cell. Mol. Life Sci. 63, 1805-1811
39. Nerelius, C., Alvelius, G., and Jörnvall, H. (2010) N-terminal segment of proinsulin C-peptide active in insulin interaction/desaggregation. Biochem. Biophys. Res. Commun. 403, 462-467
40. Chen, L.-M., Yang, X.-W., and Tang, J.-G. (2002) Acidic residues on the N-terminus of proinsulin C-Peptide are important for the folding of insulin precursor. J. Biochem. 131, 855-859
41. Munte, C.E., Vilela, L., Kalbitzer, H.R., and Garratt, R.C. (2005) Solution structure of human proinsulin C-peptide. FEBS J. 272, 4284-4293
42. Henriksson, M., Nordling, E., Melles, E., Shafqat, J., Sta? hlberg, M., Ekberg, K., Persson, B., Bergman, T., Wahren, J., Johansson, J., and Jörnvall, H. (2005) Separate functional features of proinsulin C-peptide. Cell. Mol. Life Sci. 62, 1772-1778
43. Ohtomo, Y., Bergman, T., Johansson, B.-L., Jörnvall, H., and Wahren, J. (1998) Differential effects of proinsulin C-peptide fragments on Na+, K+-ATPase activity of renal tubule segments. Diabetologia 41, 287-291
44. Lindahl, E., Nyman, U., Melles, E., Sigmundsson, K., Sta? hlberg, M., Wahren, J., Obrink, B., Shafqat, J., Joseph, B., and Jörnvall, H. (2007) Cellular internalization of proinsulin C-peptide. Cell. Mol. Life Sci. 64, 479-486
45. Jägerbrink, T., Lindahl, E., Shafqat, J., and Jörnvall, H. (2009) Proinsulin C-peptide interaction with protein tyrosine phosphatase 1B demonstrated with a labeling reaction. Biochem. Biophys. Res. Commun. 387, 31-35
46. Lindahl, E., Nyman, U., Zaman, F., Palmberg, C., Cascante, A., Shafqat, J., Takigawa, M., Savendahl, L., Jörnvall, H., and Joseph, B. (2010) Proinsulin C-peptide regulates ribosomal RNA expression. J. Biol. Chem. 285, 3462-3469
47. Choi, K.S., Fogg, D.K., Yoon, C.S., and Waisman, D.M. (2003) p11 regulates extracellular plasmin production and invasiveness of HT1080 fibrosarcoma cells. FASEB J. 17, 235-246
48. Hawley, S.B., Tamura, T., and Miles, L.A. (2001) Purification, cloning, and characterization of a profibrinolytic plasminogen-binding protein, TIP49a. J. Biol. Chem. 276, 179-186